美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

科兴生物

6.47

0.0000

成交量：- -

成交额：- -

市值：4.65亿

市盈率：-7.80

高：6.47

开：6.47

低：6.47

收：6.47

52周最高：6.47

52周最低：6.47

股本：7,186.07万

流通股本：3,116.90万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.8300

每股收益(LYR):1.06

净资产收益率：25.15%

总资产收益率：11.46%

市净率：0.62

市盈率(LYR):6.13

数据加载中...

总览公司新闻公告

停牌7年后，科兴生物重新满足纳斯达克持续上市要求，退市警报暂时解除

每日经济新闻

科兴生物宣布延长此前宣布的特别现金股息付款指示提交截止日期

科兴生物发布2025年半年报，纳斯达克摘牌风险暂解

科兴生物：2025上半年营收1.303亿美元，研发投入1.27亿美元

南方财经网

科兴控股上半年海外营收大增近三成，对冲国内市场下滑

国产甲肝疫苗独家中标阿曼两年订单

科兴流感疫苗在阿拉伯联合酋长国获批注册

科兴获准维持纳斯达克上市地位，需在5月11日前完成财报报送

纳斯达克批准科兴维持上市地位

科兴生物董事会争斗再起波澜退市危机依旧待解

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SVA/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVA\",,,,,undefined,":{"symbol":"SVA","market":"US","secType":"STK","nameCN":"科兴生物","latestPrice":6.47,"timestamp":1781553600000,"preClose":6.47,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":31169000,"shares":71860702,"eps":-0.83,"marketStatus":"停牌","change":0,"latestTime":"06-15 16:00:00 EDT","open":6.47,"high":6.47,"low":6.47,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.83,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1781596800000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1102482000000,"exchange":"NASDAQ","adjPreClose":6.47,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVA\",,,,,undefined,":{"symbol":"SVA","floatShares":31169000,"roa":"11.46%","roe":"25.15%","lyrEps":1.055174,"shares":71860702,"dividePrice":0,"high":6.47,"amplitude":0,"preClose":6.47,"low":6.47,"week52Low":6.47,"pbRate":"0.62","week52High":6.47,"institutionHeld":0.1888,"latestPrice":6.47,"eps":-0.83,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.83,"open":6.47,"prevYearClose":6.47,"prevWeekClose":6.47,"prevMonthClose":6.47,"prevQuarterClose":6.47,"fiveDayClose":6.47,"twentyDayClose":6.47,"sixtyDayClose":6.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SVA\",params:#limit:5,,,undefined,":[{"date":"2025-07-08","symbol":"SVA","amount":55,"announcedDate":"2025-04-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-23","defaultRemindTime":1751981400000,"name":"科兴生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-05-23","currency":"USD","dateTimestamp":1751947200000,"payDate":"2025-07-07"},{"market":"US","date":"2022-04-29","symbol":"SVA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1651204800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-12-31","symbol":"SVA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1640926800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-09-17","symbol":"SVA","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1631851200000,"reportTimeType":"post","actualEps":-0.05},{"market":"US","date":"2021-06-29","symbol":"SVA","fiscalQuarterEnding":"2021/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1624939200000,"reportTimeType":"","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SVA\",market:\"US\",,,undefined,":[{"executeDate":"2025-07-08","recordDate":"2025-05-23","paymentDate":"2025-07-07","value":55,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SVA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SVA","date":"2021-09-21","current":-7.795181,"percent":0.24257,"low":-100.201212,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"high":42.074882,"avg":0.136365,"sd":42.133061,"marketCap":642436987},"quantilePoints":[{"date":"2021-06-18","current":5.82081,"twenty":-61.894113,"median":23.44385,"eighty":29.57901,"marketCap":642436987},{"date":"2021-06-25","current":5.82081,"twenty":-62.119913,"median":23.213593,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-02","current":5.82081,"twenty":-62.119913,"median":22.996932,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-09","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-16","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-23","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-30","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-06","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-13","current":5.82081,"twenty":-61.894113,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-20","current":5.82081,"twenty":-61.894113,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-27","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-03","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-10","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-17","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-24","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-01","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-08","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-15","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-22","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-29","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-11-05","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-11-09","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987}],"updateTime":1781550913717},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SVA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643780556","title":"停牌7年后，科兴生物重新满足纳斯达克持续上市要求，退市警报暂时解除","url":"https://stock-news.laohu8.com/highlight/detail?id=2643780556","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643780556?lang=zh_cn&edition=fundamental","pubTime":"2026-06-16 09:48","pubTimestamp":1781574480,"startTime":"0","endTime":"0","summary":"6月15日晚间，科兴生物（Nasdaq：SVA）公告称，公司已于6月5日提交2025年20-F表格年度报告，并收到纳斯达克听证顾问的通知函，确认公司目前符合纳斯达克全球市场持续上市要求。但公司仍处于强制“小组监督期”内，直至2027年5月20日。自2019年2月22日起，科兴生物普通股在纳斯达克的交易因股东权利计划争议被暂停，至今仍未恢复。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606163772539337.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606163772539337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128905472","title":"科兴生物宣布延长此前宣布的特别现金股息付款指示提交截止日期","url":"https://stock-news.laohu8.com/highlight/detail?id=1128905472","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128905472?lang=zh_cn&edition=fundamental","pubTime":"2026-05-21 18:33","pubTimestamp":1779359607,"startTime":"0","endTime":"0","summary":"科兴生物宣布，将延长此前已宣布的特别现金股息的付款指示提交截止日期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634869497","title":"科兴生物发布2025年半年报，纳斯达克摘牌风险暂解","url":"https://stock-news.laohu8.com/highlight/detail?id=2634869497","media":"新京报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634869497?lang=zh_cn&edition=fundamental","pubTime":"2026-05-09 15:36","pubTimestamp":1778312208,"startTime":"0","endTime":"0","summary":"5月8日晚间，科兴生物（纳斯达克股票代码：SVA）披露2025年半年度财报（未经审计），报告期内，公司销售收入1.3亿美元，同比微增1.24%；归属于普通股股东的净亏损为2170万美元。研发投入1.27亿美元，占同期营收比激增至97.4%。截至目前，科兴生物已完成纳斯达克要求的截至2024年年报及2025年半年报的报送，摘牌风险暂时解除。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605093732214995.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605093732214995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["QDTE","SVA","TQQY","ONEQ","03086","NDX","BK4139","IYW","QQQE","BK4007",".IXIC","QYLG","PSQ","QQQY","FTEC","SQQQ","159632","QID","NQmain","ARTL","JEPQ","QQQA","QQQJ","QQQM","TECS","NVIW.SI","BK1147","QLD","MNQmain","TQQQ","GPIQ","QQQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634998724","title":"科兴生物：2025上半年营收1.303亿美元，研发投入1.27亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2634998724","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634998724?lang=zh_cn&edition=fundamental","pubTime":"2026-05-09 10:22","pubTimestamp":1778293320,"startTime":"0","endTime":"0","summary":"南方财经5月9日电，记者获悉，5月8日晚，科兴生物（SinovacBiotechLtd.）公布2025年上半年财报。财报显示，截至6月30日的六个月内，公司总销售额为1.303亿美元，较去年同期微增1.2%；但受资产减值及投资收益波动影响，归属于普通股股东的净亏损为2170万美元，而去年同期为净利润9390万美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605093732153243.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634770495","title":"科兴控股上半年海外营收大增近三成，对冲国内市场下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2634770495","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634770495?lang=zh_cn&edition=fundamental","pubTime":"2026-05-09 09:13","pubTimestamp":1778289180,"startTime":"0","endTime":"0","summary":"科兴控股2025年半年报显示出其业务重心的明显转移。财报显示，公司上半年海外销售额同比增长29.4%，主要得益于流感疫苗及甲肝疫苗在国际市场的出口增长。而中国内地市场受出生率下降及疫苗价格竞争影响，需求明显放缓。公司管理层在财报中表示，将坚定执行全球化战略，持续深耕海外市场。海外市场正逐步成为公司业绩的核心支撑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2026-05-09/doc-inhxhcxp3768936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605400557","title":"国产甲肝疫苗独家中标阿曼两年订单","url":"https://stock-news.laohu8.com/highlight/detail?id=2605400557","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605400557?lang=zh_cn&edition=fundamental","pubTime":"2026-01-23 14:18","pubTimestamp":1769149080,"startTime":"0","endTime":"0","summary":"近日，科兴甲型肝炎灭活疫苗孩尔来福®独家中标阿曼2026-2027年度公费市场项目。自2022年进入阿曼市场，科兴凭借产品质量、供应时效和物流保障等优势，逐步建立可靠信誉，最终获独家供应资格。海合会六国免疫规划疫苗此前多由跨国药企供应，此次中标意味着科兴产品质量与国际履约能力获海合会国家信任，是其中东非市场重要突破。截至目前，科兴甲肝疫苗孩尔来福®已累计向全球近50个国家和地区供应超1.3亿剂次，成为全球使用最广泛的甲肝灭活疫苗之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123143029a6a3c30a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123143029a6a3c30a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605556400","title":"科兴流感疫苗在阿拉伯联合酋长国获批注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2605556400","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605556400?lang=zh_cn&edition=fundamental","pubTime":"2026-01-23 14:00","pubTimestamp":1769148032,"startTime":"0","endTime":"0","summary":"1月23日，据”SINOVAC科兴”消息，近日，科兴流感疫苗正式获得阿拉伯联合酋长国卫生与预防部（MOHAP）颁发的药品注册证书。截至目前，科兴季节性流感疫苗已在全球20余个国家和地区广泛使用，累计供应量已超1.2亿剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012314003297a31120&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012314003297a31120&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605492982","title":"科兴获准维持纳斯达克上市地位，需在5月11日前完成财报报送","url":"https://stock-news.laohu8.com/highlight/detail?id=2605492982","media":"澎湃新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605492982?lang=zh_cn&edition=fundamental","pubTime":"2026-01-22 21:57","pubTimestamp":1769090264,"startTime":"0","endTime":"0","summary":"昔日凭新冠疫苗走红的科兴或有机会维持纳斯达克上市地位。1月22日晚间，科兴控股生物技术有限公司（Nasq：SVA，以下简称“科兴生物”）官网发布消息称，公司已正式获得纳斯达克听证委员会批准，将继续维持在纳斯达克全球市场的上市地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601223627701015.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601223627701015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["QQQY","NQmain","TSYW.SI","QQQE","SQQQ","BK4007","QQQJ","PSQ","TQQQ","QID","GPIQ","SVA","MNQmain","NVIW.SI","USJW.SI","QLD","JEPQ","QYLD","BK1147","QYLG","USAW.SI"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2605746006","title":"纳斯达克批准科兴维持上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2605746006","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605746006?lang=zh_cn&edition=fundamental","pubTime":"2026-01-22 19:14","pubTimestamp":1769080471,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["QQQY","SQQQ","QYLD","QYLG","MNQmain","TSYW.SI","SVA","GPIQ","QID","QQQM","QQQJ","JEPQ","QLD","QQQE","BK4007","BK1147","TQQQ","NVIW.SI","USAW.SI","QQQ","USJW.SI","PSQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593477341","title":"科兴生物董事会争斗再起波澜 退市危机依旧待解","url":"https://stock-news.laohu8.com/highlight/detail?id=2593477341","media":"央广财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593477341?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 21:25","pubTimestamp":1766582704,"startTime":"0","endTime":"0","summary":"央广网北京12月24日消息（记者邹煦晨）面临退市危机的科兴生物（NASDAQ:SVA），董事会争斗有了最新进展。近日，该公司在其官网披露，安提瓜高等法院作出临时裁决，SimonAnderson、付山、焦树阁、卢毓琳、裘育敏、王宇、阎焱及尹卫东组成公司的董事会履行公司董事会职权，直至2025年特别股东大会争议案（下称“股东会议争议案”）庭审。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512243600985033.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","SVA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}